Stacy Chin explains why R&D startups should pursue SBIR and STTR grants. These federal programs fund early-stage, high-risk research without demanding immediate commercial returns, letting founders chase breakthrough innovations that venture capital won't touch.
So the SBIR and STTR program are uniquely positioned to support early-stage R&D activities, particularly those that involve a higher degree of risk. And this characteristic is a fundamental aspect that sets this program apart from typical private investment channels. And these federal programs understand the nature of scientific and technology innovation. It's a path fraught with uncertainty, and breakthroughs can be very unpredictable. So providing funding for these types of R&D efforts These grants enable startups to undertake ambitious, innovative projects without the pressure of immediate commercial success.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
